Frequency and Sociodemographic Determinants of Depression in Patients with Chronic Liver Disease
Keywords:
Chronic liver disease, Depresson, PHQ-9Abstract
Objective:
To determine the frequency and Sociodemographic determinants of depression in patients with chronic liver disease.
Methods:
A descriptive cross-sectional study was conducted among CLD patients with 15-50 years of age of either gender having at least 6 months of illness duration were included. The depression among CLD patients were observed through PHQ-9 scoring system. This information along with patient age, gender, marital status, educational status, employment status, socioeconomic status, duration of illness and PHQ-9 scores were collected.
Results:
A total of 143 patients were included. Majority (n=77, 53.85%) patients were presented with <45 years of age. There were 73 (51.05%) females and 70 (48.95%) males. Frequency of depression was observed in 45 (31.47%) patients. A significant association of depression was observed with age (p-value 0.011), gender (pvalue <0.001), educational status (p-value 0.002), employment status (p-value 0.022), and socioeconomic status (p-value <0.001).
Conclusion: This study has found depression to be remarkably prevalent among patients with Chronic Liver Disease with age, gender, educational status, employment status, and socioeconomic status as significant risk factors.
Downloads
References
DeJean D, Giacomini M, Vanstone M, Brundisini F. Patient experiences of depression and anxiety with chronic disease: a systematic review and qualitative meta-synthesis. Ont Health Technol Assess Ser 2013; 13:1-33.
Lindert J, von Ehrenstein OS, Grashow R, Gal G, Braehler E, Weisskopf MG. Sexual and physical abuse in childhood is associated with depression and anxiety over the life course: systematic review and meta-analysis. Int J Public Health 2014; 59:359-72.
Weinstein AA, Kallman Price J, Stepanova M, Poms LW, Fang Y, Moon J, et al. Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C. Psychosomatics 2011; 52:127-32.
Coughlan B, Sheehan J, Hickey A, Crowe J. Psychological well-being and quality of life in women with an iatrogenic hepatitis C virus infection. Br J Health Psychol 2002; 7:105- 16.
Schafer A, Wittchen HU, Seufert J, Kraus MR. Methodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C - a critical review. Int J Methods Psychiatr Res 2007; 16:186-201.
Maurer DM, Darnall CR. Screening for depression. Am Fam Physician 2012; 85:139-44.
Arroll B, Goodyear-Smith F, Crengle S, Gunn J, Kerse N, Fishman T, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med 2010; 8:348-53.
Richardson LP, Rockhill C, Russo JE. Evaluation of the PHQ-2 as a brief screen for detecting major depression among adolescents. Pediatrics 2010; 125:e1097- e11039.
vanSteenbergen-Weijenburg KM, de Vroege L, Ploeger RR, Brals JW, Vloedbeld MG, Veneman TF, et al. Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics. BMC Health Sery Res 2010; 10:235.
Gureje O, Simon GE, Von Korff M. A cross-national study of the course of persistent pain in primary care. Pain 2001; 92:195–200
Sullivan MD, Edlund MJ, Zhang L, Unutzer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med 2006; 166:2087–93
Pinto-Meza A, Serrano Blanco A, Penarrubia MT Assessing depression in primary care with the PHQ-9; can it be carried out over the telephone? J Gen Int Med 2005; 8:738-42.
Wells KB, Golding JM., Burnam MA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1988; 145:976-81.
Von Korff M, Scott KM, Gureje O, Global Perspectives on Mental Physical Comorbidity in the WHO World Mental Health Surveys. Cambridge, UK: Cambridge University Press; 2009.
Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008; 31:2383–90.
Sullivan M, Simon G, Spertus J, Russo J. Depressionrelated costs in heart failure care. Arch Intern Med 2002; 162:1860–6.
Vander Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A. Depression and the risk for cardiovascular diseases: systematic review and metaanalysis. Int J Geriatr Psychiatry 2007; 22:613-26.
Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003; 54:216- 26.
Bifulco A, Moran PM, Ball C, Bernazzani O. Adult attachment style. I: Its relationship to clinical depression. Soc Psychiatry Psychiatr Epidemiol 2002; 37:50–9.
Roshanaei-Moghaddam B, Katon W. Premature mortality from general medical illness among persons with bipolar disorder: a review. Psychiatr Serv 2009;60:147–56.
Katon W, Russo J, Lin EH. Depression and diabetes: factors associated with major depression at five-year follow-up. Psychosomatics 2009; 50:570–9.
Kendler K, Gardner C, Prescott C. Toward a comprehensive developmental model for major depression in women. Am J Psychiatry 2002; 159:1133–45.
Caspi SK, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, et al. Influence of life stress on depression: moderation by apolymorphism in the 5-HTT gene. Science 2003; 301:386-9.
Bifulco A MP, Ball C, Lillie A. Adult attachment style II: Its relationship to psychosocial depressivevulnerability. Soc Psychiatry Psychiatr Epidemiol 2002;37:60–7.
Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of comorbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med 2006; 23:1165–73.
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Shafi Mansoor, Anum Haider, Zoobia Ramzan, Rahat Usman
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Articles published in the Journal of Dow University of Health Sciences are distributed under the terms of the Creative Commons Attribution Non-Commercial License https://creativecommons.org/ licenses/by-nc/4.0/. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal. 
